About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Cardiovascular Pharmacotherapy Focus

Citation:

European Cardiology Review 2019;14(2):116

Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries

Citation:

European Cardiology Review 2019;14(2):97–102

Testosterone and the Heart

Citation:

European Cardiology Review 2019;14(2):103–10

Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians Different from Caucasians?

Citation:

European Cardiology Review 2018;13(2):112–4.